Affordable Insulin Options in the US: A Complete 2025 Guide
For millions of Americans living with diabetes, insulin isn’t optional — it’s a life-sustaining medication. Yet the cost of insulin in the United States has long been a source of financial hardship, forcing people to ration doses, skip refills, or make impossible choices between insulin and other basic needs. The good news is that there are more affordable insulin options available today than ever before, from over-the-counter insulins at major retailers to manufacturer savings programs and new biosimilar products entering the market.
This guide breaks down every legitimate pathway to lower-cost insulin so you can make informed decisions and stay healthy without going broke.
—
Understanding Why Insulin Is So Expensive in the US
Before diving into solutions, it helps to understand the problem. The United States has historically paid far more for insulin than any other developed country. A vial of insulin that costs a few dollars to manufacture can retail for hundreds of dollars, largely because of complex pricing arrangements between pharmaceutical manufacturers, pharmacy benefit managers (PBMs), and insurers.
The insulin market has traditionally been dominated by three major manufacturers — Novo Nordisk, Eli Lilly, and Sanofi — who produce the most widely prescribed analog insulins. Until recently, limited competition and patent protections helped keep prices high.
However, the landscape is shifting. Recent legislation, manufacturer pricing caps, and the entry of biosimilar insulins are beginning to change the equation for many patients. If you’re paying full price for insulin right now, there’s a very real chance you’re eligible for a lower-cost option you haven’t yet explored.
—
Over-the-Counter Insulin: The Cheapest Immediate Option
One of the most overlooked affordable insulin options in the US is the availability of certain insulins without a prescription. Older human insulins — specifically NPH (intermediate-acting) and Regular (short-acting) insulin — are sold over the counter at most major pharmacies without requiring a prescription.
ReliOn Insulin at Walmart
Walmart’s ReliOn brand insulin is arguably the most well-known OTC insulin option. Available at Walmart pharmacy counters in most states, ReliOn insulins are priced at around $25 per vial — a fraction of the cost of analog insulins. The ReliOn line includes:
- **ReliOn N** (NPH insulin — intermediate-acting)
- **ReliOn R** (Regular insulin — short-acting)
- **ReliOn 70/30** (a pre-mixed combination)
These are human insulins, not the newer analog insulins like glargine (Lantus) or aspart (NovoLog). They work differently and require more careful timing around meals. If you’re currently using an analog insulin, do not switch to OTC human insulin without consulting your doctor first — improper use can lead to dangerous blood sugar swings.
That said, for people who are uninsured or underinsured and need an immediate, affordable option, OTC insulin at Walmart can be a temporary lifeline while other arrangements are made.
Kroger and Other Retailers
Some Kroger-branded pharmacies and other retail chains also offer generic or store-brand human insulins at reduced prices. It’s worth calling your local pharmacy to ask about no-prescription-required options.
—
Manufacturer Patient Assistance Programs
All three major insulin manufacturers offer Patient Assistance Programs (PAPs) that can provide insulin at little or no cost to qualifying patients. These programs are typically income-based and designed for uninsured or underinsured individuals.
Eli Lilly — Insulin Value Program
Eli Lilly made headlines in 2023 when it capped the out-of-pocket cost of all its insulins at $35 per month for most patients, regardless of insurance status. Through its Lilly Insulin Value Program, eligible patients can get a monthly supply of Lilly insulins — including Humalog and Basaglar — for $35 or less. Visit Lilly’s official website or ask your pharmacist about enrolling.
Novo Nordisk — Patient Assistance Program
Novo Nordisk offers assistance through its NovoCare program. Uninsured patients who meet income requirements may qualify for free or deeply discounted insulin. Novo Nordisk also caps insulin costs at $99 per month for uninsured patients who don’t qualify for the full assistance program.
Sanofi — Insulins Valyou Savings Program
Sanofi’s savings program can reduce the cost of Toujeo, Lantus, and Admelog for qualifying patients. Income thresholds and eligibility rules apply, and enrollment can be completed online or through your healthcare provider.
Pro tip: These programs change frequently. Always check the manufacturer’s official website or call their customer service line for the most current eligibility requirements and pricing.
—
Biosimilar Insulins: A Growing Category
One of the most significant recent developments in affordable insulin is the arrival of biosimilar insulins — products that are highly similar to existing brand-name insulins and are generally priced lower.
What Are Biosimilars?
Biosimilars are not exact copies (called generics) because insulin is a biological product. However, they are rigorously tested and FDA-approved as safe and effective alternatives to their reference products.
Key Biosimilar Insulins Available in the US
- **Semglee (insulin glargine-yfgn)** — A biosimilar to Lantus (long-acting insulin), approved by the FDA and often available at significantly lower cost than the brand-name version. Semglee received FDA designation as an “interchangeable biosimilar,” meaning pharmacies can substitute it for Lantus without a new prescription in many states.
- **Civica Insulin** — A nonprofit-developed insulin initiative aimed at providing affordable insulins (including glargine, aspart, and lispro) at costs under $30 per vial. Availability is expanding.
- **Rezvoglar** — Another insulin glargine biosimilar introduced by Eli Lilly at a lower price point.
Ask your doctor or pharmacist whether a biosimilar option is appropriate for your insulin regimen. If you’re already managing your condition well with a brand-name insulin, a biosimilar version of that same insulin may work just as effectively for considerably less money. This connects well to understanding your overall insulin resistance diet plan — because what you eat can influence how much insulin your body needs.
—
Insurance, Copay Cards, and Government Programs
Using Your Health Insurance Effectively
If you have health insurance, your first step should be understanding your plan’s formulary — the list of covered drugs and their cost tiers. Insulins are not always covered at the same level, and sometimes a similarly effective insulin that is on your plan’s formulary will cost far less than one that isn’t.
Ask your doctor if they can prescribe an insulin that’s Tier 1 or Tier 2 on your insurance plan. Switching to a formulary-preferred insulin can dramatically reduce your monthly out-of-pocket costs.
Copay Assistance Cards
Manufacturer copay cards are available for most brand-name insulins and can reduce your out-of-pocket cost to as little as $0–$35 per month if you have commercial insurance. Note: these cards typically cannot be used with Medicare or Medicaid.
Medicare Part D and the Inflation Reduction Act
The Inflation Reduction Act (IRA), signed into law in 2022, includes an important provision capping Medicare Part D out-of-pocket insulin costs at $35 per month per covered insulin. If you’re a Medicare beneficiary, this cap applies as of January 2023 — a significant saving for many seniors.
Medicaid
Medicaid covers insulin for eligible low-income individuals, and cost-sharing is generally minimal. If your income has recently decreased or you’ve lost employer coverage, it’s worth checking whether you now qualify for Medicaid in your state.
Community Health Centers
Federally Qualified Health Centers (FQHCs) operate on a sliding-fee scale and often have access to the 340B Drug Pricing Program, which allows them to purchase medications — including insulin — at substantially reduced prices and pass those savings on to patients. Use the HRSA website to find a health center near you.
—
State and Nonprofit Assistance Programs
Several states have enacted their own insulin affordability laws, and numerous nonprofit organizations offer help to people struggling with diabetes costs.
State Insulin Pricing Laws
States like Colorado, Maine, and California have passed laws capping monthly insulin costs for state-regulated insurance plans. Check with your state’s insurance commissioner or department of health to understand what protections may apply to you.
Nonprofit and Charitable Organizations
- **JDRF** and **American Diabetes Association** maintain resource directories for financial assistance.
- **NeedyMeds** (needymeds.org) is a database of patient assistance programs across all conditions.
- **Partnership for Prescription Assistance** connects patients with manufacturer programs.
- **RxAssist** maintains a directory of PAPs and is searchable by medication.
Managing the cost of insulin is just one piece of the puzzle. Understanding how to manage diabetes at work and keeping your blood sugar stable day-to-day can also reduce the total amount of insulin you need, which helps control costs over time.
—
Tips to Reduce How Much Insulin You Need
While finding affordable insulin is critical, it’s also worth exploring evidence-based strategies to improve your insulin sensitivity — which can reduce the total amount of insulin your body requires.
- **Exercise regularly:** Physical activity improves insulin sensitivity. Even a 30-minute walk after meals can meaningfully lower blood sugar. Read our [guide on diabetes and exercise benefits](https://www.affordablediabetesoptions.com/diabetes-and-exercise-benefits/) for more detail.
- **Follow a low-glycemic diet:** Reducing refined carbohydrates and added sugars lowers post-meal blood sugar spikes.
- **Maintain a healthy weight:** Even modest weight loss can improve insulin sensitivity in people with Type 2 diabetes.
- **Monitor consistently:** Keeping close tabs on your blood sugar patterns helps you and your doctor fine-tune your dosing and avoid over-prescribing.
These lifestyle changes don’t replace insulin — especially for Type 1 diabetics — but they can help Type 2 diabetics reduce their required doses and overall medication costs.
—
Conclusion
The cost of insulin in the United States remains a serious problem, but there are more pathways to affordability than most people realize. From OTC human insulins at Walmart to manufacturer savings programs, biosimilars, Medicare caps, and state-level protections, you have real options — and you don’t have to navigate them alone.
Start by talking to your doctor or pharmacist about your current insulin, your insurance coverage, and which programs you might qualify for. Never ration or skip insulin doses without medical guidance, as doing so can have severe health consequences.
Staying informed, advocating for yourself, and using every available resource is the best strategy for managing both your diabetes and your budget.
—
Disclaimer: This article is for informational purposes only and does not constitute medical or financial advice. Always consult a licensed healthcare provider before making changes to your insulin regimen.
Frequently Asked Questions
Can I buy insulin over the counter without a prescription in the US?
Yes, certain older human insulins — including NPH (N) and Regular (R) — are available without a prescription at Walmart and some other pharmacies. Walmart’s ReliOn insulin is available for around $25 per vial. However, these are not the same as modern analog insulins, and you should consult your doctor before switching.
How can I get insulin for $35 a month?
Several pathways exist. Eli Lilly caps its insulin at $35/month for most patients through its Insulin Value Program. Medicare Part D beneficiaries are also capped at $35/month per covered insulin under the Inflation Reduction Act. Manufacturer copay cards can also bring costs to $35 for commercially insured patients.
Are biosimilar insulins as effective as brand-name insulins?
Yes. FDA-approved biosimilar insulins go through rigorous testing to confirm they are as safe and effective as their reference (brand-name) products. The FDA has designated some biosimilars, like Semglee, as “interchangeable” with their brand-name counterparts, meaning they can be substituted at the pharmacy level in many states.
What should I do if I can’t afford my insulin right now?
Contact the insulin manufacturer directly — all three major manufacturers (Eli Lilly, Novo Nordisk, Sanofi) have patient assistance programs. You can also visit a Federally Qualified Health Center (FQHC) for sliding-scale care, check NeedyMeds.org for assistance programs, or ask your pharmacist about OTC insulin options as a short-term bridge while you explore other options. Never ration insulin without medical supervision.



Leave a Reply